VEGFA and neoplasm: Immunoblots of tumor extracts (Figure 5C) confirmed the decrease in Chkα protein in the 231 VEGF tumors following siRNA NP treatment, whereas Chkα protein in treated 231 WT tumors remained comparable to protein levels in untreated 231 WT and VEGF tumors.